Molecular drivers of metastatic disease in breast cancer - European Medical Journal

Molecular drivers of metastatic disease in breast cancer

Oncology

At the European Cancer Congress (ECC) 2015, Giuseppe Curigliano, MD, PhD, of Istituto Europeo di Oncologia, Milan, Italy, explains that genetic differences between primary and metastatic breast cancer may have important clinical implications, including for the identification of biomarkers for disease progression.

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given